Barbie kriegt Trump-Klatsche: Handelskrieg schickt Mattel ins Spielzeug-Desaster
06-05-2025 11:16 via wallstreet-online.de

Barbie kriegt Trump-Klatsche: Handelskrieg schickt Mattel ins Spielzeug-Desaster

Der US-Spielwarenriese Mattel hat seine Finanzprognose für das laufende Jahr kassiert. Grund sind steigende Kosten infolge der neuen Importzölle, die US-Präsident Donald Trump Anfang des Jahres gegen China verhängt hat.
Jetzt den vollständigen Artikel lesen
Weiterlesen »

Analysten nachrichten



Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company’s Vision AI Platform Technology
Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company’s Vision AI Platform Technology
Elmos Semiconductor SE: Q1 scheint den Tiefpunkt zu markieren
Elmos Semiconductor SE: Q1 scheint den Tiefpunkt zu markieren
Quartalsbericht: Rekordgewinn: Ferrari gibt Gas – drückt vor aber Trumps Zöllen auf die Bremse
Quartalsbericht: Rekordgewinn: Ferrari gibt Gas – drückt vor aber Trumps Zöllen auf die Bremse
ANALYSE-FLASH: Deutsche Bank belässt Hugo Boss auf 'Hold' - Ziel 43 Euro
ANALYSE-FLASH: Deutsche Bank belässt Hugo Boss auf 'Hold' - Ziel 43 Euro
RONN-Saudi Arabia JV Greenlit: Multi-Billion Dollar Hydrogen Expansion to Anchor Vision 2030, Set Over Three Years
RONN-Saudi Arabia JV Greenlit: Multi-Billion Dollar Hydrogen Expansion to Anchor Vision 2030, Set Over Three Years
ANALYSE-FLASH: Warburg senkt Freenet auf 'Hold' - Hebt Ziel auf 35,30 Euro
ANALYSE-FLASH: Warburg senkt Freenet auf 'Hold' - Hebt Ziel auf 35,30 Euro
Original-Research: Zalando SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Original-Research: Zalando SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
Upexi Increases Solana Treasury to 201,500 Solana Tokens for $30 Million and Begins to Generate Staking Revenue
Upexi Increases Solana Treasury to 201,500 Solana Tokens for $30 Million and Begins to Generate Staking Revenue
United States Antimony Corporation Announces Webcast set for Thursday, May 8, 2025, at 4:15 PM Eastern Time on Record First Quarter 2025 Financial and Operating Results
United States Antimony Corporation Announces Webcast set for Thursday, May 8, 2025, at 4:15 PM Eastern Time on Record First Quarter 2025 Financial and Operating Results
Scepter Holdings, Inc, to Add Marketing Executive, Natalie Guzman, to Advisory Board
Scepter Holdings, Inc, to Add Marketing Executive, Natalie Guzman, to Advisory Board
Netlist Reports First Quarter 2025 Results
Netlist Reports First Quarter 2025 Results
MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity
MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity
Desktop versie